On Wednesday, Following U.S. Stocks were among the “Top Losers”: InspireMD, (NYSEMKT:NSPR), Sunoco Logistics Partners, (NYSE:SXL), Molycorp, (NYSE:MCP), Brown Shoe, (NYSE:BWS)

InspireMD, (NYSEMKT:NSPR), with shares dwindled -7.11%, closed at $0.26.

Sunoco Logistics Partners, (NYSE:SXL), with shares declined -7.09%, settled at $40.10.

Molycorp, (NYSE:MCP), with shares dipped -7.07%, and closed at $0.76.

Brown Shoe, (NYSE:BWS), dropped -6.39%, and closed at $30.01.

Latest NEWS regarding these Stocks are depicted underneath:

InspireMD, Inc. (NYSEMKT:NSPR)

InspireMD, Inc. (NSPR), declared the closing of its offering of about 34.4 million shares of ordinary stock and warrants to purchase about 34.4 million shares of ordinary stock. The ordinary stock was sold at a negotiated purchase price of $0.40 per share, and each purchaser received a warrant to purchase one share of ordinary stock for each share of ordinary stock that it purchased in the offering. The warrants are exercisable right away and have a term of exercise of five years from the date of issuance and an exercise price of $0.55 per share. The Corporation received gross proceeds from the offering of about $13.7 million, before deducting placement agents’ fees and estimated offering expenses.

H.C. Wainwright & Co., LLC served as the sole bookrunner for this offering. Dawson James Securities, Inc. served as co-manager.

InspireMD seeks to utilize its proprietary MGuard® with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

Sunoco Logistics Partners L.P. (NYSE:SXL)

Sunoco Logistics Partners L.P. (SXL), declared that it has priced its formerly declared public offering of 13,500,000 ordinary units at $41.76 per unit. The underwriters of this ordinary unit offering have been granted an option to purchase up to 2,025,000 additional ordinary units. The offering was made following an effective shelf registration statement on Form S-3 formerly filed with the Securities and Exchange Commission. The Partnership intends to use the net proceeds from this offering to repay outstanding borrowings under its $1.5 billion revolving credit facility and for general partnership purposes.

Morgan Stanley, Barclays, BofA Merrill Lynch, UBS Investment Bank, Wells Fargo Securities, J.P. Morgan, Goldman, Sachs & Co., Credit Suisse, RBC Capital Markets and Jefferies are acting as the joint book-running managers for the ordinary unit offering.

Sunoco Logistics Partners L.P. (SXL), headquartered in Philadelphia, is a master limited partnership that owns and operates a logistics business comprising of a geographically diverse portfolio of complementary crude oil, refined products, and natural gas liquids pipeline, terminalling and attainment and marketing assets which are used to facilitate the purchase and sale of crude oil, refined products, and natural gas liquids. SXL’s general partner is a merged partner of Energy Transfer Partners, L.P. (ETP).

Molycorp, Inc. (NYSE:MCP)

Molycorp, Inc. (MCP), declared that it will release financial results for the fourth quarter and full year ended December 31, 2014 after the market closes on Monday, March 16, 2015. Release of Molycorp’s financial results will be followed by an investor conference call on Tuesday, March 17, 2015 at 9:00 a.m. Eastern, hosted by Geoff Bedford, President and Chief Executive Officer, and Michael Doolan, Executive Vice President and Chief Financial Officer.

Molycorp is the only advanced material manufacturer in the world that both controls a world-class rare earth resource and can produce high-purity, custom engineered rare earth products to meet increasingly demanding customer specifications.

Brown Shoe Co. Inc. (NYSE:BWS)

Brown Shoe Co. Inc. (BWS), stated fourth quarter 2014 financial results, with net sales of $615.4 million up 2.6% as compared to fourth quarter 2013 net sales of $600.0 million. Fourth quarter 2014 stated net earnings of $16.2 million, or $0.37 per diluted share, comprised of $0.17 per diluted share of adjustments, primarily related to the sale of Shoes.com in December 2014. Adjusted net earnings of $9.0 million, or $0.20 per diluted share, were up 45.5% contrast to stated net earnings of $6.2 million, or $0.14 per diluted share, in the fourth quarter of 2013. Gross margin was flat year-over-year, at 40.2%, while operating earnings of $12.7 million were up 24.7%.

For the full year, the corporation stated net sales of $2,571.7 million up 2.3% as compared to 2013 net sales of $2,513.1 million. Stated net earnings for 2014 were $82.8 million, or $1.89 per diluted share, as compared to $38.1 million, or $0.88 per diluted share, in 2013. Adjusted net earnings for 2014 were $75.6 million, or $1.72 per diluted share, and were up 23.0% contrast to 2013 adjusted net earnings of $61.5 million, or $1.41 per diluted share. Gross margin was flat year-over-year, at 40.4%, while operating earnings of $125.9 million were up 27.7%.

“Both of our business segments assisted drive fourth quarter results, with Famous Footwear delivering strong same-store-sales growth of 4.0% while Brand Portfolio sales improved 5.4%. Both segments also delivered good improvement in adjusted operating margin for the quarter, with Famous Footwear up 90 basis points and Brand Portfolio adjusted operating margin up 160 basis points,” said Diane Sullivan, CEO, president and chairman of Brown Shoe Corporation. “This is in addition to record adjusted operating earnings for 2014 and good year-over-year improvement in adjusted operating margin - up 80 basis points to 5.0%.”

Brown Shoe Corporation, Inc., a footwear corporation, retails and wholesales footwear worldwide. The corporation operates through Famous Footwear, Wholesale Operations, Specialty Retail, and Other segments.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.